These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
505 related articles for article (PubMed ID: 19491186)
1. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. Patel M; Pedreira C; De Oliveira LH; Tate J; Orozco M; Mercado J; Gonzalez A; Malespin O; Amador JJ; Umaña J; Balmaseda A; Perez MC; Gentsch J; Kerin T; Hull J; Mijatovic S; Andrus J; Parashar U JAMA; 2009 Jun; 301(21):2243-51. PubMed ID: 19491186 [TBL] [Abstract][Full Text] [Related]
2. Duration of protection of pentavalent rotavirus vaccination in Nicaragua. Patel M; Pedreira C; De Oliveira LH; Umaña J; Tate J; Lopman B; Sanchez E; Reyes M; Mercado J; Gonzalez A; Perez MC; Balmaceda A; Andrus J; Parashar U Pediatrics; 2012 Aug; 130(2):e365-72. PubMed ID: 22753550 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Boom JA; Tate JE; Sahni LC; Rench MA; Hull JJ; Gentsch JR; Patel MM; Baker CJ; Parashar UD Pediatrics; 2010 Feb; 125(2):e199-207. PubMed ID: 20083525 [TBL] [Abstract][Full Text] [Related]
4. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua. Mast TC; Khawaja S; Espinoza F; Paniagua M; Del Carmen LP; Cardellino A; Sánchez E Pediatr Infect Dis J; 2011 Nov; 30(11):e209-15. PubMed ID: 21768920 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala. Gastañaduy PA; Contreras-Roldán I; Bernart C; López B; Benoit SR; Xuya M; Muñoz F; Desai R; Quaye O; Tam KI; Evans-Bowen DK; Parashar UD; Patel M; McCracken JP Clin Infect Dis; 2016 May; 62 Suppl 2():S121-6. PubMed ID: 27059345 [TBL] [Abstract][Full Text] [Related]
14. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). Cortese MM; Parashar UD; MMWR Recomm Rep; 2009 Feb; 58(RR-2):1-25. PubMed ID: 19194371 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of rotavirus vaccination in Argentina. Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States. Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD Pediatr Infect Dis J; 2013 Mar; 32(3):278-83. PubMed ID: 23014356 [TBL] [Abstract][Full Text] [Related]
17. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. Shui IM; Baggs J; Patel M; Parashar UD; Rett M; Belongia EA; Hambidge SJ; Glanz JM; Klein NP; Weintraub E JAMA; 2012 Feb; 307(6):598-604. PubMed ID: 22318281 [TBL] [Abstract][Full Text] [Related]
18. Hospital-based surveillance and analysis of genotype variation in Nicaragua after the introduction of the pentavalent rotavirus vaccine. Khawaja S; Cardellino A; Mast TC Pediatr Infect Dis J; 2014 Jan; 33(1):e25-8. PubMed ID: 24042492 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units. Thrall S; Doll MK; Nhan C; Gonzales M; Perreault T; Lamer P; Quach C Vaccine; 2015 Sep; 33(39):5095-102. PubMed ID: 26296493 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD Pediatrics; 2010 Feb; 125(2):e208-13. PubMed ID: 20100757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]